About the RADIAL trial

Benefits and challenges of participating in the RADIAL trial

health and benefit  - Desktop health and benefit mobile

Benefits and challenges of participating in the RADIAL trial

Benefits and challenges of participating in the RADIAL trial

Challenges you might experience if you join the RADIAL trial 

Recruitment closed

Alongside the potential benefits, you will also need to consider the potential challenges of taking part in the RADIAL trial: 

Important responsibilities, including finger-pricking

You may already be accustomed to finger-pricking but the thought of doing this on a daily basis may not be appealing. That is completely understandable. But this will provide you with vital information about how to adjust your insulin dose and gain the benefits, so the researchers will be relying on you to do this regularly. You will also have other responsibilities including recording information through trial apps. If you decide to join the trial, you’ll need to take these responsibilities seriously.

No guarantee of health benefit

Although being in the RADIAL trial could improve your blood glucose management, this is not guaranteed. It is also possible that you might experience side effects, but of course this can also happen in usual diabetes care. It’s important to remember that Toujeo® is an approved treatment which many people with diabetes around the world are taking.

Need to get accustomed to new technology

Finally, you’ll need to become accustomed to the technologies that enable participation in the trial without visiting a hospital clinic. However, you will be given training and IT support throughout the trial whenever needed.

RADIAL trial timeline (decentralised group)

timeline desktop - Desktop timeline image

The RADIAL trial will last for about 7½ months. The first six weeks will be the screening phase where the research team will make certain the trial is suitable for you. You will continue on your current long-acting basal insulin during this period.

The main treatment period of the trial – where you will receive Toujeo® – will last for 6 months (24 weeks), with three scheduled video calls with the trial doctor. 

You’ll be self-injecting Toujeo® once a day using a disposable injection pen and ultra-fine needle. Your Toujeo® pen cap will automatically record the dose, date and time each time you inject.

Recruitment closed

What you’ll need to do if you join the RADIAL trial 

Testing your blood glucose regularly is a very important part of the RADIAL trial. This will be done by pricking your finger with a sterilised lancet and using a 'smart' glucometer that will automatically transfer blood glucose readings to your trial apps.

You will need to do this every morning during the time taken to find the most appropriate dose of Toujeo® and after that, three times a week.  You should also do it if you suspect a hypo may be happening. 

The thought of finger-pricking on a daily basis may be worrying or unappealing at first, but most people become accustomed to it fairly quickly.

Doing this is vital as it guides adjustment of your insulin dose and helps you gain the most benefit from it. 

On three occasions, you will also need to provide a few drops of blood from your finger for measuring your HbA1c level (a measure of your average blood glucose over time). You will be given additional instructions on how to do this and how to send the sample to the research team.

Recruitment closed
What other trial responsibilities will you have?
What medical support will be provided?
What will happen after the trial?
What equipment will you need for the trial?
What training and support will be provided?

You will need to download two trial apps. These will set up automatic recording of your blood glucose readings and dosages/times of Toujeo® injections and provide access to an electronic diary (e-diary) where you’ll be able to record important trial data, join scheduled video calls with the trial doctor, receive reminders and messages, and contact the research team.

Both apps used in the trial are secure, virus-free and will respect your privacy.

Help and support with the technology will be available from the research team whenever you may need it. 

References
  1. Gale EAM et al. Diabetes Care 2007; 30(12): 2989-2992 
  2. https://care.diabetesjournals.org/content/30/12/2989.long
  3. Becker RHA et al Diabetes Care 2015; 38:637–643 
  4. Riddle MC et al Diabetes Care 2014; 37(10): 2755-62 
  5. Bolli GB et al Diab Obes Metab 2015; 17: 386–394
  6. Yki-Jarvinen H et al Diabetes Care 2014; 37:3235–3243